Clinical trial
Evaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate Cancer
NCT04225299
Study timeline
Study start (estimated)2020-03-31Date precision: day
Registry last updated2020-11-13
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Localized Prostate Cancerunresolved
Interventions
TOOKAD®DRUG
Sponsors & collaborators
Steba Biotech S.A.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04225299 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.